These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8383273)

  • 1. Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin.
    Braun JE; Severson DL
    Lipids; 1993 Jan; 28(1):59-61. PubMed ID: 8383273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
    Braun JE; Severson DL
    Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts.
    Severson DL; Lee M; Carroll R
    Mol Cell Biochem; 1988 Jan; 79(1):17-24. PubMed ID: 3374475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
    Braun JE; Severson DL
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
    Persson E
    Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
    Carroll R; Juhasz A; Severson DL
    Biochem J; 1990 Sep; 270(2):391-5. PubMed ID: 2169239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
    Rodrigues B; Braun JE; Spooner M; Severson DL
    Can J Physiol Pharmacol; 1992 Sep; 70(9):1271-9. PubMed ID: 1493594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro release of lipoprotein lipase and hepatic lipase by low molecular weight heparins.
    Meraihi Z; Lutz O; Frey A; Bach AC
    Arch Int Pharmacodyn Ther; 1989; 297():286-93. PubMed ID: 2543347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of lipoprotein lipase and hepatic lipase activities. Effects of heparin and a low molecular weight heparin fragment.
    Persson E; Nilsson-Ehle P
    Scand J Clin Lab Invest; 1990 Feb; 50(1):43-9. PubMed ID: 2156335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term incubation of cardiac myocytes with isoprenaline has no effect on heparin-releasable or cellular lipoprotein lipase activity.
    Severson DL; Carroll R; Kryski A; Ramírez I
    Biochem J; 1987 Nov; 248(1):289-92. PubMed ID: 2829825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of heparin and low molecular weight heparin on lipid transport during parenteral feeding in the rat.
    Roth B; Ekelund M; Fan BG; Ekstrom U; Nilsson-Ehle P
    Acta Anaesthesiol Scand; 1996 Jan; 40(1):102-11. PubMed ID: 8904267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of taxol on the heparin-induced secretion of lipoprotein lipase from cardiac myocytes.
    Severson DL; Carroll R
    Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):17-22. PubMed ID: 2571074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
    Rodrigues B; Spooner M; Severson DL
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol-specific phospholipase C releases lipoprotein lipase from the heparin releasable pool in rat heart cell cultures.
    Chajek-Shaul T; Halimi O; Ben-Naim M; Stein O; Stein Y
    Biochim Biophys Acta; 1989 Nov; 1014(2):178-83. PubMed ID: 2554975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term incubation of cardiac myocytes with oleic acid and very-low density lipoprotein reduces heparin-releasable lipoprotein lipase activity.
    Rodrigues B; Spooner MR; Severson DL
    Mol Cell Biochem; 1992 Oct; 116(1-2):33-7. PubMed ID: 1480152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
    Rodrigues B; Severson DL
    Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of lipoprotein lipase after heparin administration.
    Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
    Arterioscler Thromb; 1993 Oct; 13(10):1391-6. PubMed ID: 8399074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1996 Nov; 74(11):1204-9. PubMed ID: 9028578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.